The abstract is read at the publisher; the summary is JClub's.
In east and southeast Asia, inflammatory bowel disease is progressing through four epidemiological stages, with many countries currently in stage 2 where incidence acceleration is compounding prevalence.
- Why it matters: Newly industrialised regions are still transitioning, and rising incidence in stage 2 is a growing public health concern with an increasing future burden.
- What they did: This Review traces a 100-year trajectory across Japan, South Korea, China, Hong Kong, and Malaysia, from first reported cases in 1920s Japan to the present, mapping each region’s position within stage 2.
- The result: Cross-regional patterns in east and southeast Asia can guide interventions for the rising global burden and may serve as a model for other emerging regions expected to follow a similar trajectory.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.